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Abstract.  Leukocytes form zones of close apposition 
when they adhere to ligand-coated surfaces. Because 
plasma proteins are excluded from these contact zones, 
we have termed them protected zones of adhesion.  To 
determine whether platelets form similar protected 
zones of adhesion,  gel-filtered platelets stimulated with 
thrombin or ADP were allowed to adhere to fibrinogen- 
or fibronectin-coated surfaces.  The protein-coated sur- 
faces with platelets attached were stained with either 
fluorochrome-conjugated goat anti-human  fibrinogen or 
anti-human  fibronectin antibodies, or with rhodamine- 
conjugated polyethylene glycol polymers. Fluorescence 
microscopy revealed that F(ab'h anti-fibrinogen (100 
kD) did not penetrate into the contact zones between 
stimulated platelets and the underlying fibrinogen- 
coated surface, while Fab antifibrinogen  (50 kD) and 
10 kD polyethylene glycol readily penetrated and 
stained the substrate beneath the platelets.  Thrombin- 
or ADP-stimulated platelets also formed protected 
zones of adhesion on fibronectin-coated surfaces. 
F(ab')2 anti-fibronectin and  10 kD polyethylene glycol 
were excluded from these adhesion zones, indicating 
that they are much less permeable than those formed 
by platelets on fibrinogen-coated surfaces.  The perme- 
ability properties of protected zones of adhesion formed 
by stimulated platelets on surfaces coated with both 
fibrinogen and fibronectin were similar to the zones of 
adhesion formed on fibronectin alone,  mAb 7E3, di- 
rected against the a~b/33 integrin blocked the formation 
of protected adhesion zones between thrombin-stimu- 
lated platelets and fibrinogen or fibronectin coated sur- 
faces, mAb C13 is directed against the otS/~l integrin 
on platelets,  Stimulated platelets treated with this mAb 
formed protected zones of adhesion on surfaces coated 
with fibronectin.  These protected zones were imper- 
meable to F(ab')2  antifibronectin but were permeable 
to  10 kD polyethylene glycol. These results show that 
activated platelets form protected zones of adhesion 
and that the size of molecules excluded from these 
zones depends upon the composition of the matrix 
proteins to which the platelets adhere.  They also show 
that formation of protected zones of adhesion by plate- 
lets requires ot~3 integrins while the permeability 
properties of these zones of adhesion are regulated by 
both OdIIb•3 and ot513~ integrins. 
T 
HE formation  of a  platelet (Pit) ~ plug  at the  site  of 
vascular injury can be divided into three steps:  first, 
adhesion of resting  PIts to the subendothelial  matrix. 
Second, stimulation  of Pits,  which promotes Pit spreading 
and recruitment of additional  Pits, to form an aggregate re- 
ferred to as a Plt plug. Third,  simultaneous  secretion of vari- 
ous mediators from the Pits.  These mediators stabilize  the 
plug by promoting the recruitment of more Pits into the plug 
and by facilitating  the formation  of a fibrin clot (Fitzgerald 
and Phillips,  1989; Leung and Nachman,  1986). 
1. Abbreviations  used in this paper: Fg, fibrinogen; PEG, polyethylene gly- 
col; Pit, platelet; PZA, protected zones of adhesion. 
Adhesion  of Pits  to  extracellular  matrices  and  Pit-Pit 
aggregation  are mediated by specific Plt receptors. For ex- 
ample,  upon activation,  Pit integrin  t~3  mediates  attach- 
ment  and  spreading  of  Pits  on  matrices  containing 
fibrin/fibrinogen  (Peerschke,  1985),  von Willebrand  factor 
(Timmons et al., 1984) and fibronectin  (Plow et al., 1985). 
Pit receptors other than cttr~/~3 also participate  in Pit adhe- 
sion. For example, the glycoprotein Ib-IX complex mediates 
adhesion of Pits to yon Willebrand  factor (Roth,  1991), and 
several  members  of the  ~t  integrin  superfamily  serve as 
receptors for collagen (Kunicki et al., 1988), fibronectin (Pi- 
otrowicz et al., 1988) and laminin (Sonnenberg et al., 1988) 
in the subendothelial  matrix. 
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bridging  of  dimeric  fibrinogen  (Fg)  molecules  between 
ct~  integrins on adjacent Plts is required for Pit aggrega- 
t~orx (Bennett et al., 1982). Although fibrinogen is the major 
piotein involved  in Pit aggregation, other proteins such as 
,on WiUebrand factor (Turitoo et  al.,  1984),  vitronectin 
~hiagarjan  and  Kelly,  1988),  thrombospondin  (Leung, 
~4), and fibronectin (Dixit et al.,  1985) also are thought 
be involved in this process. 
Microscopic analyses of Plt plugs and aggregates show 
that Pits are closely opposed to each other and to underlying 
matrix proteins (Zucker and Nachmias, 1985). While there 
are  no  data  describing  the  ability of plasma  proteins  to 
permeate into the spaces between Plts and extracellular ma- 
trices  or  other  Pits,  Coller  (1990) reported  that Pit-rich 
thrombi  are  particularly  resistant  to  thrombolysis.  This 
raises the possibility that thrombolytic agents have limited 
activity against such thrombi because they cannot gain ac- 
cess to the contact regions between aggregated Pits or be- 
tween Pits and extracellular matrix proteins. 
Several  investigators  have  reported  that  neutrophils 
(Campbell et al.,  1982;  Sandhaus,  1987; Rice and Weiss, 
1990;  Weitz et al.,  1987; Wright et al.,  1988) and macro- 
phages (Wright and Silverstein, 1984;  Heiple et al.,  1990) 
have the capacity to form a tight seal between their mem- 
branes  and  ligand-coated  surfaces.  Electron  microscopic 
(Wright and Silverstein,  1984),  and reflection interference 
contrast microscopic (Heiple et al.,  1990)  studies indicate 
that this seal surrounds a space(s) between the macrophages 
and the underlying ligand-coated surface. The tightness of 
the seal has been characterized by its capacity to exclude 
soluble extracellular proteins from the interface between the 
cell and the substrate. There is evidence that these protected 
zones of adhesion play a significant role in the effector func- 
tions of ceils. For example, chemoattractant-stimulated neu- 
trophils form such protected zones as they adhere to Fg- 
coated surfaces or as they migrate through filters coated with 
Fg  (Weitz  et  al.,  1987; Wright  et  al.,  1988).  Elastase 
secreted by the neutrophils into these zones is protected from 
inactivation by proteinase inhibitors present in the surround- 
ing medium (Weitz et al.,  1987).  Such findings have led us 
(Weitz et al.,  1987; Wright et al., 1988; Wright and Silver- 
stein, 1984; Heiple et al., 1990) and others (Campbell et al., 
1982; Sandhaus, 1987; Rice and Weiss, 1990) to suggest that 
the protected zones of adhesion formed between leukocytes 
and extracellular matrices serve as sites at which secretory 
products  function without interference by inhibitory sub- 
stances present in plasma. 
In this paper, we report that activated Pits form protected 
extracellular zones of adhesion when they adhere to Fg- and 
fibronectin-coated surfaces. Plts adhering to Fg- or fibrin- 
coated surfaces form seals that exclude molecules of 100 kD, 
but are permeable to molecules of 50 kD. In contrast, Pits 
adhering to surfaces coated with either fibronectin alone or 
with a mixture of fibronectin and Fg form tighter seals that 
exclude molecules greater than 8 kD. Thus, the permeability 
properties of  protected zones of  adhesion formed by Pits vary 
depending upon the composition of the matrix to which the 
Pits  adhere.  In  addition,  we  report  that the  Pit  integrin 
C~tr~3 mediates the formation of protected zones of adhe- 
sion, while both u,rd33 and c~s/3~ integrins regulate the per- 
meability properties of such contact zones. 
Materials and Methods 
Reagents 
Human Fg (grade L; Kabi AB, Stockholm) was depleted of plasminogen by 
lysine Sepharose 4B affinity  chromatography in the presence of aprotinin 
(100 Kallikrein inhibition U/ml). It migrated as three bands of unequal in- 
tensity on reduced SDS PAGE, corresponding to the A~,B/3  and 3' chains. 
Human plasma derived fibronectin was a kind gift of Dr. B. Horowitz, the 
New York Blood Center (New York, NY). ADP was obtained from Sigma 
Chemical Co. (St. Louis, MO). Anti aird33 antibody (7E3) was a kind gift 
of Barry CoUer (State University of NY at Stony Brook, Stony Brook, NY) 
and anti-c~5/31 (CP13)  was obtained from Oncogene Sciences Inc. (Manhas- 
set, NY). 
Protein-coated Surfaces 
Individual wells on glass microslides (Carlson Scientific, Peotone, IL) were 
coated with either Fg or fibronectin by adding 20 tzl of a  solution (250 
pg/mi) in PBS containing calcium and magnesium to each well for either 
1-4 h [for Fg] or 8 h [for fibronectin] in a humidified chamber at room tem- 
perature. The amount of protein adhering per well was assayed directly on 
the wells using the Micro BCA protein assay reagent kit (Pierce Chemical 
Co., Rockford, IL). Wells coated with either Fg or fibronectin comained 
"~3.0 and 3.5  #g per well, respectively. Glass coated with both Fg and 
fibronectin was prepared by adding 20/~l of a solution containing 125/~g/ml 
of Fg and 125 ~g/mi fibronectin in PBS containing calcium and magnesium 
to each well for up to 8 h. Under these conditions, each well was coated 
with -4/~g of protein per well. Protein-coated microslides were washed 
three times with PBS and used immediately for experiments. 
Collection of  Platelets 
PIts were collected as described (Silverstein and Nachman,  1987)  by gel 
filtration of Pit-rich plasma at 22-24°C through Sepharose 2B (Pharmacia 
Fine Chemicals,  Piscataway,  NJ),  equilibrated with Hepes-buffered Ty- 
rode's solution (137 mM NaCI, 2.7  mM KC1, 3.3 mM Na2PO4,  5.5 mM 
glucose and 10 mM Hepes, pH 7.4).  Fractions rich in Pits were pooled, 
diluted to •1-2  ×  l0  s Plts/ml with Tyrode's buffer containing 1 mg/ml hu- 
man serum albumin and sufficient divalent cations to bring the final CaCI2 
and MgCI2 concentrations to 1 and 0.5 mM, respectively. Plts were used 
for experiments within 60 min after isolation. 
Platelet Adhesion and the Formation of  Protected 
Zones of  Adhesion 
Thrombin-stimulated Plts were prepared by incubating resting Pits with 1 
NIH unit/ml of thrombin (a gift from Dr. John Fenton; New York State 
Department of Health, Albany, NY) for 5 rain at room temperature and then 
adding PPACK (Calbiochem Corp., La Jolla, CA; 10  -5 M final concentra- 
tion) to inactivate the thrombin. ADP-stimulated Pits were prepared by in- 
cubating Pits with 1/~M ADP for 5 rain at room temperature. Stimulated 
PIts or untreated Pits were then allowed to adhere to protein-coated glass 
microslides at room temperature. After a  10-rain  incubation, the micro- 
slides were washed five times in Tyrode's buffer and fixed at room tempera- 
ture for 15 min with 3.7% formaldehyde. The Pits were washed again with 
Tyrode's buffer and incubated with various fluorescein or rhodamine con- 
jugated probes or antibodies at room temperature for 60 min. The prepara- 
tion then was washed with Tyrode's buffer and immediately observed by 
phase and fluorescent microscopy at a magnification of 400.  The number 
of adherent Plts per nun  2 was determined using phase microscopy; four 
random fields were counted in each of at least two separate wells. Pho- 
tomicrographs were taken with either Kodak EktaKrome Professional color 
slide film (ASA 800/1600)  or with Tri-Pan X black and white film. 
Fluorescein- and Rhodamine-conjugated Probes 
Fluorescein-conjugated  F(ab%  fragments  of  goat  anti-human  Fg  and 
fluorescein-conjugated F(ab')2  fragments of goat anti-human fibronectin 
were  purchased  from  Organon  Teknika  (Rockville,  MD).  Rhodamine- 
conjugated F(ab')2 and Fab fragments of mouse mAb 4A5 (Matsueda et al., 
1988),  directed against an epitope at the carboxy terminus of the 3' chain 
of human Fg, were prepared by purifying the antibody from ascites fluid 
using Affi-gel DEAE Blue (BioRad Labs, Richmond, CA) (Matsueda and 
Bernatowicz, 1988) and then digesting the antibody with papain (Parharm, 
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F(ab')2 fragment of 4A5 (Goding,  1985).  Rhodamine conjugates of these 
fragments were prepared as described (Harlow and Lane,  1988) to give 
rhodamine: fragment ratios of 0.89 and 1.24 for F(ab')2 and Fab, respec- 
tively. Antibodies and their fragments were brought to a concentration of 
I mg/ml in PBS and then diluted 1:20 for staining protein-coated surfaces. 
Rhodamine-conjugated polyethylene glycol (PEG) was prepared from PEG 
of different rnol wt (3.5, 5, 8, and 10 kD; from Sigma Chemical Co.). Solid 
PEG (0.02 retool) was dissolved in 0.5 ml dimethylformamide. Solid rhoda- 
mine B (115 rag, 0.22 retool), N-hydroxysuccinimide (25 nag, 0.22 mmol) 
and 4-dimethylaminopyridlne (28 nag, 0.22 mmol) were added sequentially. 
Solid BOP reagent (97 rag, 0.22 retool) (Advanced Chemtech Inc., Louis- 
ville, KY) was added to this viscous suspension at room temperature. After 
stirring for 20 h, 9.5 rnl 0.1 M aqueous HC1 was added and rapidly mixed 
into the resulting dark red viscous solution. The dark colored insoluble ma- 
teriai which precipitated was separated by centrifugation at 1,000 rpm (500 
g). Three ml of the supornatant was applied to a freshly prepared Bio-Gel 
P-2 (1.5 x  16.5 era) column equilibrated with 0.1 M aqueous HC1. The prod- 
uct was eluted from the column with 0.1 M HC1. Visual observation indicated 
separation of rhodamine-conjugated PEG from unreacted rhodamine and its 
byproducts. The first set of red fractions (6-8 ml, total vol) contained the 
rhodamine-conjugated product. Rhodarnine content of conjugates was esti- 
mated from absorbance at 560 nm based upon an observed extinction co- 
efficient of 79,400 M -1 cm  -t for rhodamine B in 0.1 M  HC1.  The rhoda- 
mine-conjugated products were stable in solution for at least 8 mo when 
stored at 4°C, as judged by SDS PAGE and gel filtration experiments. 
Results 
Stimulated Platelets Form Protected  Zones of  Adhesion 
when They Adhere to Fibrinogen-coated  Surfaces 
Freshly isolated human PIts were stimulated in suspension 
with either thrombin or ADP and allowed to adhere to Fg- 
coated surfaces as described in Materiais and Methods. As 
shown in Fig. 1 (A and B), both ADP- and thrombin-stimu- 
lated Pits readily adhered to and spread on Fg-coated sur- 
faces. Incubation  of  the Pit-containing wells with fluorescein- 
conjugated F(ab')2 fragments of goat anti-human Fg, stained 
the Fg-coated surface except in areas directly underneath the 
thrombin-stimulated Pits (Fig. 1 E). A similar staining pat- 
tern was observed using rhodamine-conjugated F(ab')2 frag- 
ments of monoclonal 4A5 anti-Fg antibody (Fig. 1 F). Be- 
cause each of these conjugated antibodies recognizes a dif- 
ferent epitope on Fg, the lack of staining underneath Pits is 
not  a function  of  the antibody  preparation used. The unstained 
area beneath thrombin- or ADP-stimulated Pits appeared as 
a black area on fluorescence microscopy. A dense spot of 
fluorescent staining was observed in the center of thrombin- 
stimulated Pits (Fig. 1 E). It is likely that these stained de- 
posits on the Pit surfaces represent Fg that was secreted by 
the Pits onto their apical membranes after thrombin stimula- 
tion because: (a) this spot was generally not seen in Pits stim- 
ulated with concentrations of ADP that do not stimulate Pit 
degranulation (Kroll and Schafer,  1989,  and unpublished 
data); and (b)  these stained deposits were removed when 
thrombin-stimulated Pits were treated with detergent before 
the addition of anti-Fg antibodies (see below). 
The absence of fluorescent F(alY)2 staining underneath the 
ADP- or thrombin-stimulated Pits could result from exclu- 
sion of the probe from the Plt-Fg contact zone or from Fg 
degradation by the Pits, thereby rendering the extracellular 
Fg unreactive to anti-Fg antibodies. To differentiate between 
these two possibilities, thrombin-stimulated Pits were first 
allowed to adhere to Fg-coated surfaces for 15 min, fixed 
with formaldehyde, and then treated for an additional 10 rain 
with a 0.1% SDS solution to permeabilize the plasma mem- 
branes of the Pits. The Pits were then washed with buffer. 
Under these conditions, fluorescein-conjugated F(ab')2 frag- 
ments of goat anti-human Fg stained both underneath and 
around the Pits (not shown), indicating that the Fg under- 
neath the Pits was intact and remained immunoreactive. In 
addition, no dense spot of fluorescent staining was observed 
after SDS treatment of  thrombin-stimulated Pits (not shown), 
confirming that this stained material can be removed from 
Pit surfaces by detergent. These results suggest that the un- 
stained areas (black in the color photographs) are created be- 
cause these fluorescent probes do not gain access into the 
zones of close contact between Pits and the underlying Fg- 
coated surface. The shape of  each unstained  area corresponds 
in outline to the perimeter of a Pit and delineates a protected 
zone of adhesion beneath a single Pit. 
We also examined the effects of temperature on the forma- 
tion of protected zones of adhesion by Pits and of formalde- 
hyde fixation on  their  appearance.  As  shown  in  Fig.  1, 
thrombin- (Fig.  1 C) and ADP- (Fig.  1 G) stimulated Pits 
formed protected zones of  adhesion that excluded fluorescent 
probes in the absence of  formaldehyde  fixation. The protected 
zones of adhesion observed when Pits were first fixed and 
then incubated with F(ab')2 were approximately the same 
size as those observed when Pits were fixed after incubation 
with F(alY)2. Allowing ADP- or thrombin-stimulated Pits to 
adhere to Fg-coated surfaces at 37°C vs 22°C did not affect 
the size of protected zones of adhesion formed by Pits (not 
shown). 
Stimulation of Pits increased the proportion of adherent 
Pits that formed protected zones of  adhesion (Fig. 2). Greater 
than 95% of thrombin-stimulated, and 86% of ADP-stimu- 
lated Pits formed protected zones of adhesion. In contrast, 
only 26 % of unstimulated PIts formed zones of contact be- 
tween the Pits and Fg-coated surfaces that excluded fluores- 
cein-conjugated F(ab')2 anti-human Fg. 
Platelet Integrin ~m#33 Is Required  for the 
Formation of  Protected  Zones of  Adhesion Between 
Platelets and Fibrinogen-coated  Surfaces 
Because binding of  activated Pits to soluble or surface-bound 
Fg is primarily mediated by the integrin ot~fl3 (Bennett et 
ai., 1982), we evaluated the role of  this integrin in the forma- 
tion of protected zones of adhesion. Thrombin-stimulated 
Pits were incubated with 10 pg/ml of mAb 7E3  (directed 
against the Fg-binding site of integrin o~m~3 [Coller et al., 
1983]) for 10 min at room temperature, and the mixture then 
was added to surfaces coated with Fg. Under these condi- 
tions (Fig. 1, D and H), <15% of the Pits adhered to the sur- 
face.  Furthermore,  <5%  of the  few Pits that did adhere 
formed protected zones of  adhesion. Similar results were ob- 
tained using ADP-stimulated Pits (not shown). These results 
substantiate earlier observations (Peerschke, 1985) that the 
integrin ol~/~3 is primarily responsible for Pit adhesion to 
Fg-coated surfaces, and indicate that this integrin plays an es- 
sential role in the formation of protected zones of adhesion 
by Pits adherent to Fg-coated surfaces. 
Platelets Form Protected  Zones of  Adhesion when They 
Adhere to Fibronectin-coated  Surfaces 
Pits  readily  adhere  to  matrices  containing  fibronectin. 
Therefore, we examined whether untreated or stimulated Pits 
form protected zones of adhesion when they adhere to fibro- 
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zones of contact between  stimu- 
fated Pits and Fg-coated surfaces: 
ADP- or thrombin-stimulated  Pits 
were prepared  and allowed to ad- 
here  to  Fg-eoated  glass  wells 
(,03.0  #g/well)  for 5 rain  as de- 
scribed under Materials and Meth- 
ods.  As indicated  in the text,  the 
fibrinogen  on the surface of the 
wells was visualized  by incubat- 
ing the wells with either fluores- 
cein  or  rhodamine-conjugated 
F(ab')2  fragments  of anti-human 
Fg and was observed under phase 
or  fluorescence  microscopy.  A 
(phase) and E (fluorescence):  ad- 
herent  thrombin-stimulated  Pits 
were fixed with formaldehyde and 
incubated with fluorescein-conju- 
gated  F(ab')2  fragments  of goat 
anti-human  Fg  for  30  min.  B 
(phase) and F (fluorescence):  ad- 
herent ADP-stimulated  Pits were 
fixed with formaldehyde and incu- 
bated with rhodamine-conjugated 
F(ab')2  fragments  of 4A5  anti- 
human  Fg  for  30  min.  C  and 
G: adherent  ADP-stimulated  and 
thrombin-stimulated  Pits, respec- 
tively,  were  first  incubated  with 
fluorescein-conj  ugated  F(ab')2 
fragments  of goat anti-human Fg 
for 30 min and then  fixed  with 
formaldehyde.  D  (phase)  and H 
(fluorescence):  thrombin-stimu- 
lated Pits that were incubated with 
monoclonal antibody 7E3 (10 #g/ 
ml)  for  15  min  in  suspension, 
allowed to adhere to Fg-c,  oated sur- 
faces, and then stained with fluo- 
rescein-conjugated  F(ab')2  frag- 
ments of goat anti-human Fg. 
nectin-coated surfaces. Pits were allowed to adhere to fibro- 
nectin-coated surfaces under conditions similar to those de- 
scribed above for Fg-coated surfaces. The capacity of PIts to 
exclude  fluorescein-conjugated  F(ai¢)2  fragments  of  goat 
anti-human fibronectin from the Plt-fibronectin contact re- 
gion was monitored by fluorescence microscopy. Untreated 
Pits (Fig. 3, A and D), ADP-stimulated Pits (not shown), and 
thrombin-stimulated Pits (Fig. 3, B and E) formed protected 
zones of  adhesion as measured by the exclusion of  fluorescein- 
conjugated F(ab')2 fragments of goat anti-human fibronectin 
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from beneath adherent Pits.  Fixation of these preparations 
before or after incubation with anti-fibronectin F(ab32 did 
not significantly  affect the appearance of the protected zones 
of adhesion formed by ADP- or thrombin-stimulated Pits 
(Fig. 3,  C  and F). 
Although  85%  of  ADP-stimulated  Pits  and  >99%  of 
Figure 2.  Stimulation of Pits affects the percent of Pits that form 
protected  zones of adhesion on protein-coated  surfaces.  Unstimu- 
lated, ADP- or thrombin-stimulated  Pits were prepared and allowed 
to adhere to either Fg- or fibronectin-coated  glass for 5 min as de- 
scribed under Materials and Methods. The Pits were fixed and the 
glass surfaces were incubated for 30 min with either fluorescein- 
conjugated F(ab')2 fragments of goat anti-human  Fg or fluorescein- 
conjugated F(ab')2 fragments  of goat anti-human fibronectin.  The 
percent of PIts that formed protected zones of adhesion was deter- 
mined as described under Materials  and Methods  by counting at 
least four fields from three separate wells. The data are the averages 
and SEM of three separate  experiments. 
Figure 3.  F(ab')2 is excluded from zones of con- 
tact between stimulated  Pits and fibronectin-coated 
surfaces:  ADP- or thrombin-stimulated Pits were 
prepared  and allowed  to  adhere  to  fibronectin- 
coated  glass wells for 5 min as described  under 
Materials and Methods.  As indicated  in the text, 
the fibronectin-coated surfaces (•3.5  #g/well) were 
visualized by incubating the wells  with fluores- 
cein-conjugated F(ab')2  fragments  of goat  anti- 
human fibronectin  and were observed under phase 
or fluorescence microscopy. A and D are phase and 
fluorescence  micrographs,  respectively,  of ADP- 
stimulated Pits adherent to fibronectin-coated sur- 
faces. B and E are phase and fluorescence micro- 
graphs  of thrombin-stimulated Plts  adherent  to 
fibronectin-coated surfaces.  C and F are fluores- 
cence micrographs of ADP and thrombin-stimulated 
PIts that  were  allowed  to adhere  to fibronectin- 
coated surfaces, incubated for 30 min at 37°C with 
F(ab')2 fragments of goat anti-human fibronectin, 
and then fixed with formaldehyde. 
Loike et al. Platelets Form Protected Zones of Adhesion  949 Figure 4. The entry of different sized molecules into the zones of contact between Pits and Fg- or fibronectin-coated surfaces. ADP- or 
thrombin-stimulated Pits were prepared and allowed to adhere to either Fg- or fibronectin-coated  glass for 5 min as described under Materials 
and Methods. As indicated in the text, proteins adherent to the glass surfaces were visualized by incubating them with different fluorochrome- 
conjugated probes. (A and B) ADP-stimulated Pits on Fg-coated surfaces were incubated with fluorescein-conjugated Fab fragments of 
goat anti-human Fg and F(ab')2 fragments of mAb 4A5, respectively. (C and D) thrombin-stimulated Pits adherent to Fg-coated surfaces 
were incubated with fluorescein-conjugated Fab fragments of goat anti-human Fg and F(ab')2 fragments of 4A5, respectively. E and F 
show phase and fluorescence micrographs, respectively, of thrombin-stimulated Pits adhering to Fg-coated surfaces and incubated with 
rhodamine-conjugated  PEG of 10 kD. G-J show  ADP-stimulated  Pits adhering to fibronectin-coated  surfaces and incubated with rhodamine- 
conjugated PEG of 10, 8, 5, and 3.5 kD, respectively. K and L show thrombin-stimulated Pits adherent to surfaces coated with a mixture 
of Fg and fibronectin and incubated with rhodamine-conjugated PEG of 10 and 8 kD, respectively. 
thrombin-stimulated  Plts  formed protected zones of adhe- 
sion on fibronectin-coated surfaces (Fig.  2),  ~70%  of un- 
stimulated Pits formed protected zones of adhesion on fibro- 
nectin-coated surfaces. Thus, prior activation of Pits is not 
essential for the formation of protected zones of adhesion on 
fibronectin-coated surfaces. This was in marked contrast to 
the results obtained with Fg-coated surfaces on which only 
26 % of adherent unstimulated Pits  formed protected zones 
of adhesion (Fig.  2). 
Permeability of  Macromolecules into Protected Zones 
of  Adhesion Formed by Platelets 
As shown in Figs.  1 and 3, molecules of 100 kD (i.e., fluores- 
cein-conjugated F(ab32 fragments of goat anti-human anti- 
bodies), were excluded from the zones of contact formed be- 
tween stimulated  Pits and either Fg- or fibronectin-coated 
surfaces.  To examine  the  permeability  properties  of these 
protected zones of adhesion in greater detail we determine 
whether molecules of<100 kD could enter into these contact 
regions. We first examined the capacity of  ADP- or thrombin- 
stimulated Pits to exclude Fab fragments (50 kD) of anti-Fg 
antibody (4A5) from regions between adherent Pits and the 
underlying substrate.  Fab fragments of 4A5 readily pene- 
trated into the contact zones between ADP (Fig.  4 A),  or 
thrombin (Fig.  4  C),  treated  Pits  and Fg-coated surfaces. 
Parallel  experiments  confirmed that  F(ab3~- fragments  of 
goat anti-human Fg or of 4A5 were excluded from the pro- 
tected  zones  of adhesion  formed  by  thrombin-  or  ADP- 
stimulated Pits on Fg-coated surfaces (see Fig.  1, B and D 
and data not shown). Thus, molecules of 50 kD permeated 
into protected zones of adhesion formed by Pits on Fg-coated 
surfaces while molecules of 100 kD did not permeate into 
these  zones.  The  observation  that  Fab  fragments  of 4A5 
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ported above (with SDS-treated Plts) that the Fg in these 
regions remains immunoreactive. 
To  investigate the  permeability  properties  of protected 
zones  of adhesion  formed between  Pits  and  fibronectin- 
coated surfaces, we conjugated rhodamine to PEG polymers 
of molecular weights varying between 3.5 kD and 10 kD. The 
rhodamine  conjugated  PEG  probes  chromatographed  on 
SDS  PAGE at  ~2  to  2  1/2  times the  nominal  molecular 
weight of the PEGs from which they were synthesized. For 
example, the rhodamine conjugate of 10 kD PEG migrated 
in SDS PAGE like a globular protein of ,,o 20-25 kD (not 
shown). Rhodamine-conjugated PEG probes are especially 
useful for these experiments because they bind to both Fg- 
and fibronectin-coated surfaces but do not bind to uncoated 
glass or to Plt membranes (not shown). 
All of the rhodamine-conjugated PEGs readily penetrated 
underneath thrombin- or ADP-stimulated Plts adherent to 
Fg-coated surfaces (Fig. 4, E and F, and data not shown). In 
contrast, rhodamine-conjugated PEG of 10 and 8 kD were 
excluded from the protected zones of adhesion formed by ei- 
ther ADP- or thrombin-stimulated Plts on fibronectin-coated 
surfaces  (Fig.  4,  G-I,  and data not shown).  Rhodamine- 
conjugated PEG of 3.5 kD readily permeated into the contact 
zones between Plts and fibronectin-coated surfaces (Fig. 4 
J). Subtle differences were noted in the permeation of 10-, 
8-,  and 5-kD probes into the protected zones of adhesion 
formed by  these  Plts.  The  protected  zones  of adhesion 
defined by the 8- or 5-kD PEG polymers were smaller and 
their borders were less crisply demarcated than those ob- 
served when a 10-kD rhodamine-conjugated PEG probe was 
used (compare G-I in Fig. 4). We believe this reflects partial 
penetration of 8 and 5 kD rhodamine-conjugated PEG into 
the contact regions between the Plts and the underlying sub- 
strate. These results show that Plts generate a much tighter 
or closer association with the substrate when they adhere 
to fibronectin-coated surfaces than when they adhere to Fg- 
coated surfaces; they imply that the composition of the ma- 
trix determines the tightness of the seal formed between Pits 
and protein-coated surfaces. 
Fixation  did  not  affect the  permeability  properties  of 
protected zones of adhesion formed on fibronectin-coated 
surfaces. Thrombin-stimulated Plts adherent to fibronectin- 
coated surfaces were first incubated with rhodamine-conju- 
gated PEG of 10 kD and then fixed with formaldehyde. These 
Plts excluded this probe from their zones of contact with 
protein-coated surfaces as efficiently as Plts fixed before in- 
cubation with this probe (not shown). 
Protected Zones of  Adhesion Formed by 
Platelets on Surfaces Coated with Both Fibrinogen 
and Fibronectin 
A solution of equal amounts (by weight) of Fg and fibronec- 
tin was used to coat glass surfaces. The presence of each pro- 
tein on the surface was detected by staining the surface with 
the corresponding antibody.  ADP- or thrombin-stimulated 
Plts formed protected zones of adhesion on Fg/fibronectin- 
coated surfaces as measured by their capacity to exclude flu- 
orescein-conjugated F(ab')2  fragmcats  of goat anti-human 
Fg antibodies from zones of contact  t tween "-.e Plts and the 
substrate. The permeability of  these protected zones of adhe- 
sion was identical to that observed when stimulated Pits were 
plated on surfaces coated with fibronectin alone; i.e., the Pits 
excluded rhodamine-conjugated PEG polymers of 10 and 8 
kD (Fig. 4, K and L), but were permeable to rhodamine-con- 
jugated PEG polymers of 3.5 kD (not shown). Surfaces were 
also coated with Fg/fibronectin solutions in which the Fg 
concentration was maintained at 125 #g/ml, but the fibro- 
nectin concentration was reduced by fivefold to 25 #g/ml. 
Even under these conditions, the permeability of protected 
zones of adhesion formed by thrombin-stimulated Pits was 
similar to that observed on surfaces coated with a solution 
of 250/zg/ml of fibronectin alone (not shown). These results 
indicate that fibronectin exerts a dominant effect when Pits 
adhere to surfaces coated with both Fg and fibronectin; they 
suggest  that  the  permeability  characteristics  of protected 
zones of adhesion formed by Pits on substrates containing 
two different ligands will reflect those of the ligand that pro- 
motes formation of the tightest zones of contact. 
We examined the relative contribution of cX~rd33 and asBl 
integrins to the formation of protected zones of adhesion be- 
tween Plts and surfaces coated with both Fg and fibronectin. 
Plts first were stimulated with thrombin for 5 rain, treated 
with PPACK (to inactivate the thrombin), incubated in sus- 
pension for 1 h in the absence (Fig. 5, A and B), or presence 
(Fig. 5, C and D), of 5/~g/ml of anti-otlrofl3 antibody (7E3), 
and then allowed to adhere to surfaces coated with both Fg 
and fibronectin, mAb 7E3 reduced the number of adherent 
Pit by at least 80%.  Both anti-Fg F(ab')2 and  10 kD PEG 
permeated into the region between the Fg/fibronectin-coated 
substrate and the 20 % of Pits that did adhere (Fig. 5, A-D). 
mAb 7E3  inhibited thrombin-stimulated Plt adhesion and 
the  formation of protected zones of adhesion on  surfaces 
coated with Fg alone or with fibronectin alone (Fig.  1, and 
data not shown).  These results indicate that this antibody 
prevents the formation of protected zones of adhesion be- 
tween stimulated Pits and either Fg- or fibronectin-coated 
surfaces. 
In contrast, an antibody against otsBt (CP13) (5 ~tg/rnl), 
reduced thrombin-stimulated Plt adhesion to surfaces coa~d 
with Fg and fibronectin or with fihronectin alone by ,~3IS ,~ 
(not shown).  Greater inhibition of adhesion by this  ar.ti- 
fibronectin receptor antibody was not observed because th," 
Plts  can  still  attach  to  fibronectin via  the  ottr~B3 integrin 
(Philips et al., 1991). However, the permeability of the pr, 
tected  zones  of  adhesion  formed  between  thrombirt- 
stimulated Pits and surfaces coated with Fg and fibronet  . 
or with fibronectin alone was markedly altered in the pl. 
ence  of CP13  (Fig.  5,  E  and  F,  and  data  rc,  t  showl~, 
Rhodamine-conjugated 10 kD PEG penetrated tae cor,  ta~ 
regions between CP13-treated Pits and the und  dying sur- 
faces coated with  Fg  and  fibronectin or with  fibronectin 
alone (Fig. 5 F), whereas F(ab')2 anti-Fg was excluded (Fig 
5 E). These results show that formation of a protected zon~ 
of adhesion that excludes low molecular weight probes (rho- 
damine-conjugated PEG) requires the participation of both 
tXnb/33 and cts/~ receptors. 
Formation of  Protected Zones of  Adhesion Between 
Platelets and Surfaces Coated with Fibrin 
Thrombin- and ADP-stimulated Plts formed protected zor: ~: 
of adhesion on fibrin-coated surfaces (Fig. 6, A and C" 
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anti-cts/31 on  the  formation of pro- 
tected  zones  of  adhesion  between 
Plts and surfaces coated with Fg and 
fibronectin.  Pits  were  incubated  in 
suspension for 5 min in the presence 
of thrombin, and further incubated in 
Tyrode's buffer containing PPACK in 
the presence or absence of 5/~g/ml of 
the specified antibody for  1 h.  The 
Plts were then allowed to adhere for 
5 min at 37°C to surfaces coated with 
both Fg and fibronectin as described 
under Materials and Methods. A and 
B show thrombin-stimulated  Plts pre- 
incubated in  suspension for  1 h  at 
37°C with no additions and allowed 
to adhere to surfaces coated with Fg 
and  fibronectin.  The  surfaces  with 
the attached Pits then were stained 
with  fluorescein-conjugated F(ab')2 
fragments of goat anti-human Fg and 
rhodamine-conjugated PEG of 10 kD, 
respectively; C and D show thrombin- 
stimulated  Plts  preincubated  with 
mAb 7E3  (5  #g/ml)  in  suspension 
and then allowed to adhere to  sur- 
faces coated with Fg and fibronectin. 
The surfaces with the attached Pits 
were then stained with fluorescein- 
conjugated F(ab')2 fragments of goat 
anti-human  Fg  (C)  or  with  rhoda- 
mine-conjugated PEG of 10 kD (D); 
E  and F  show  thrombin-stimulated 
Plts  preincubated  with  mAb  anti- 
a5/31 (10 #g/ml) and allowed to ad- 
here to surfaces coated with Fg and 
fibronectin. The surfaces with the at- 
tached Plts were  stained with fluo- 
rescein-conjugated F(ab')2  fragments 
of goat anti-human Fg (E) or with rho- 
damine-conjugated PEG of 10 kD. (F). 
evidenced  by  exclusion  of  fluorescein-conjugated  F(ab% 
anti-human  Fg from the zones of contact between the Pits 
and these surfaces. (The fluorescein-conjugated F(ab')2 anti- 
human  Fg used  in these experiments stained fibrin-coated 
surfaces.) In contrast, rhodamine-conjugated PEG of 10 kD 
and Fab fragments of mAb 4A5 penetrated into these adhe- 
sive zones (Fig. 6, B and D, and data not shown), as observed 
when  thrombin-stimulated Pits  adhered  to  Fg-coated  sur- 
faces (Fig. 4, E  and F).  Thus,  protected zones of adhesion 
formed between Pits and fibrin-coated surfaces and between 
Pits and Fg-coated surfaces exhibited similar permeability 
properties. 
Discussion 
ADP- and thrombin-stimulated Pits form "seals" with  Fg-, 
fibrin-, and fibronectin-coated surfaces. These seals deline- 
ate protected zones of adhesion between  Pits and protein- 
coated  surfaces  and prevent molecules  in  the  surrounding 
medium from entering the cell-substrate interface. Stimula- 
tion of Pits with thrombin or with low concentrations of ADP 
significantly enhances their capacity to form protected zones 
of adhesion on Fg-coated surfaces.  Because low dose ADP 
does  not  stimulate  granule  secretion  (Kroll  and  Schafer, 
1989; Loike, Silverstein and Silverstein, unpublished data), 
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molecules  into  the  zones  of  contact 
between  thrombin  stimulated  Pits  and 
fibrin-coated surfaces. Fibrin-coated  sur- 
faces were prepared by adding 20/~1 of 
a solution of  Fg (250 t~g/ml) to glass sur- 
faces pretreated  with 2 ~,1 of a solution 
of  thrombin (1,000 U/ml). Thrombin- (A 
and B) or ADP- (C and D) stimulated 
Pits  were prepared and allowed  to ad- 
here to these protein coated surfaces for 
5 rain as described under Materials and 
Methods.  As indicated  in the text,  the 
proteins on the surfaces were visualized 
by incubating them with different fluoro- 
chrome conjugated probes.  (A) Prepara- 
tions  containing  thrombin-stimulated 
Pits stained with fluorescein-conjugated 
goat F(ab')2  anti-human Fg.  (B)  Prep- 
arations containing thrombin-stimulated 
Pits stained with rhodamine-conjugated 
PEG of 10 kD.  (C)  Preparations  con- 
taining ADP-stimulated Pits stained with 
fluorescein-conjugated  goat F(ab')2 anti- 
human Fg. (D) Preparations  containing 
ADP-stimulated  Pits stained with rhoda- 
mine-conjugated  Fab fragment of 4A5. 
it seems likely that the formation of protected zones of adhe- 
sion does not require the release of secretory products from 
Pit granules. 
The permeability  properties  of these protected  zones of 
adhesion depend upon the nature of the protein (ligand) coat- 
ing the surface (Table I). Stimulated Pits that spread on either 
Fg- or fibrin-coated surfaces exclude molecules of 100 kD 
(such as F(at¢)2) from the area between adherent Pits and the 
substrate, whereas molecules of 50 kD (such as Fab) readily 
permeate into these contact zones. In contrast, Pits adherent 
to fibronectin-coated surfaces or to surfaces coated with a 
mixture of Fg and fibronectin exclude molecules greater than 
8-10 kD. Thus, protected zones of adhesion formed between 
Pits and fibronectin-coated surfaces are less permeable than 
those formed between Pits and Fg- or fibrin-coated surfaces. 
The interaction of Pits with matrices other than Fg also is 
Table L Summary of Permeabilities of Protected Zones of Adhesion (PZA)* 
Percent of cells¢ forming 
PZA that excludes 
Size molecule 
Matrix  Antibody  excluded from PZA  >100 kD  >10 kD 
Fg  none  100 kD  >95  <5 
anti-c~n~3  no PZA  0  0 
anti-c~5/31  100 kD  >95  <5 
Fibronectin  none  8-10 kD  >95  70 
anti-am,/33  no PZA  0  0 
anti-~5/3~  100 kD  82  <5 
Fg/fibronectin  none  8-10 kD  >95  75 
anti-c~n~/33  no PZA  0  0 
anti-c~5/3~  100 kD  77  <5 
* Thrombin-stimulated Pits were preincubated in suspension  in the presence or absence  of 5 t~g/ml of either mAb 7E3 (anti-~wd53) or CP13 (anti-cxs/3~) for 60 
min at room temperature. The Pits were then allowed to adhere to the surfaces  coated with the indicated proteins as described under Materials and Methods and 
in Fig. 5.  Protected zones of adhesion were determined as described under Materials and Methods.  Protein-coated  wells containing adherent Pits were stained 
with either fluorescein-conjugated  F(ab')2 fragments of goat anti-human  Fg, fluorescein-conjugated  F(ab% fragments of goat anti-human  fibronectin,  rhodamine- 
conjugated  10 kD PEG or rhodamine-conjugated  8 kD PEG as described under Materials and Methods.  PZA =  protected  zones of adhesion. 
The percent of Pits forming PZA was determined by counting the number of Pits that excluded each probe.  Values represent the average (n  =  5) percent of 
Pits that formed PZA that excluded either 100 kD (F(ab')2 or 10 kD (rhodamine-conjugated  PEG) probes. 
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ample, Hynes et al. (1978) reported that in the presence of 
fibronectin, unstimulated Pits adhered, spread and dumped 
together on collagen-coated surfaces, whereas in the absence 
of fibronectin unstimulated Pits adhered poorly and did not 
spread or aggregate on these surfaces. 
We have explored the roles of Otxr~3 and otsB~ integrins in 
the formation of protected zones of adhesion by Pits.  mAb 
7E3, which is directed against the ligand-binding domain of 
oL~r~3, prevents Pits from forming protected zones of adhe- 
sion on Fg and fibronectin-coated surfaces, indicating that 
O~jroBa mediates this interaction. However,  the engagement 
of otsB~ integrins in addition to ot~B3 was required for stim- 
ulated Pits to form very tight (i.e., excludes 8 kD PEG) pro- 
tected zones of adhesion on surfaces containing fibronectin 
(Table I). Additional work is required to determine whether 
formation of these very tight zones of adhesion requires only 
the physical interactions of ot5/3, integrins with fibronectin 
on the substrate or whether the engagement of c~5/31 integrin 
by fibronectin further activates the Pit cytoskeleton  or modu- 
lates the adhesive properties of ot~rd~3. That the interaction 
of fibronectin receptors with substrate bound fibronectin can 
activate other integrins on the same cell has been reported 
by Wright et al. (1985) who showed that ligation of fibronec- 
tin receptors activates CD11b/CD18  on human monocyte- 
derived macrophages. Such activation is required for CDllb/ 
CD18  to promote phagocytosis of C3bi coated particles. 
Pits are not the only cells that form protected zones of 
adhesion. We and others (Campbell et al., 1982; Wright and 
Silverstein, 1984; Baron et al., 1985; Sandhaus, 1987; Weitz 
et al.,  1987; Wright et al.,  1988;  Heiple et al.,  1990;  and 
Rice and Weiss,  1990)  have shown that phagocytic leuko- 
cytes and osteoclasts form seals with substrates coated with 
a  variety of proteins including Fg, fibrin, and fibronectin. 
Formation of these seals is mediated by a number of plasma 
membrane receptors including/32 integrins (Wright and Sil- 
verstein, 1984; Wright et al., 1988; and Loike et al., manu- 
script  in  preparation),  tXird33 and  otsBt integrins  (current 
manuscript), and Fc receptors (Heiple et al.,  1990; Wright 
and Silverstein,  1984). 
Protected zones of adhesion formed by Pits  may have 
significant physiological consequences in at least two situa- 
tions:  (a)  Protected  zones  of adhesion  could  provide  a 
confined space into which Pit secretory products (e.g., c~2 
antiplasmin, or plasminogen activator inhibitor) are released 
and retained when Pits are stimulated to adhere to extracel- 
lular matrices. The extent to which these proteins diffuse out 
of these zones of adhesion will depend upon the permeability 
properties of the zones of adhesion. As we have shown, the 
permeability of protected zones of adhesion is determined in 
part by the nature of  the protein on the surfaces to which cells 
adhere. (b) Protected zones of adhesion may restrict access 
of plasma proteins and therapeutic agents to at least three 
regions in a thrombus. First is the region between Pits and 
the subendothelial matrix, which contains collagen, lami- 
nin, yon Willebrand factor and fibronectin (Sonnenberg et 
al., 1988).  Our present results suggest that protected zones 
of adhesion formed by Pits in the regions of a thrombus that 
are rich in fibronectin, such as the subendothelial matrix, 
will be vastly less permeable to substances in plasma than 
the regions in which Pits interact with one another or with 
Fg/fibrin gels. Consequently, thrombolytic  agents and plasma 
proteases (e.g., plasminogen/plasmin) of molecular weights 
between 50 and 100 kD may be excluded from the zones of 
adhesion formed between Pits and the subendothelial ma- 
trix. Second is the region between adjacent Pits in the Pit- 
rich aggregate termed the "white thrombus7 Pits in this re- 
gion bind to one another via Fg bridges. Third is the region 
between Pits and the Fg/fibrin meshwork that forms the outer 
region of a thrombus. If fibronectin (440 kD) does not pene- 
trate into these latter two regions then we expect that the pro- 
tected zones of  adhesion formed would be permeable to mole- 
cules  <50  kD  but  impermeable  to  molecules >100  kD. 
Because protected zones of adhesion may regulate the entry 
of proteases into zones of contact of Pits with one another, 
or with basement membranes, the permeability properties of 
these zones of adhesion deserve consideration in the design 
of thrombolytic agents. 
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